Profile data is unavailable for this security.
About the company
Mega Lifesciences Public Company Limited is a Thailand-based company. The Company is engaged in manufacturing and selling through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods, as well as the provision of distribution services relating to such products. Its segments include Brands, Distribution, and OEM (Original Equipment Manufacturer). The Brands segment represents a business segment in which goods are manufactured and sold under brands owned by the Company. The Distribution segment represents a service business segment in which the Company provides logistical and marketing services for goods trading purposes and the sale of goods manufactured by third parties. The OEM segment represents a business segment in which goods are manufactured by third parties under brands not owned by the Company.
- Revenue in THB (TTM)15.69bn
- Net income in THB2.02bn
- Incorporated1982
- Employees5.51k
- LocationMega Lifesciences PCLFloor 9 and 10, Ample Tower Building120 Mu 11, Bangna-Trat RoadBangnaBANGKOK 10280ThailandTHA
- Phone+66 27694222
- Fax+66 27694244
- Websitehttps://www.megawecare.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Advanced Research Co Ltd | 326.34m | -1.67bn | 31.29bn | 409.00 | -- | 57.59 | -- | 95.87 | -11.93 | -11.93 | 2.33 | 3.88 | 0.1123 | -- | 3.13 | 1,847,073.00 | -57.57 | -61.70 | -85.94 | -119.31 | 62.76 | 76.08 | -512.56 | -163.40 | -- | -244.66 | 0.3414 | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
| Harrow Inc | 5.01bn | -1.13bn | 31.31bn | 315.00 | -- | 14.30 | -- | 6.25 | -0.9079 | -0.9079 | 4.09 | 1.71 | 0.5406 | 4.21 | 6.75 | 440,244.40 | -12.21 | -10.86 | -13.79 | -12.71 | 69.77 | 70.75 | -22.59 | -15.35 | 2.75 | -0.3302 | 0.7536 | -- | 46.95 | 25.77 | -73.30 | -- | 143.88 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 20.86bn | 1.16bn | 31.47bn | 3.65k | 27.17 | 1.55 | -- | 1.51 | 0.2293 | 0.2293 | 4.13 | 4.01 | 0.4446 | 0.8832 | 7.75 | 1,149,606.00 | 3.02 | 0.6992 | 5.84 | 5.12 | 48.44 | 20.23 | 6.79 | 3.45 | 2.67 | -- | 0.1251 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Canopy Growth Corp | 7.79bn | -12.69bn | 31.85bn | 1.03k | -- | 2.06 | -- | 4.09 | -6.06 | -8.54 | 3.82 | 5.49 | 0.1589 | 2.71 | 6.89 | 288,771.60 | -25.87 | -26.08 | -35.16 | -28.67 | 26.89 | 2.59 | -162.78 | -333.29 | 1.25 | -0.5923 | 0.5585 | -- | -10.83 | 5.59 | 84.29 | -- | -64.60 | -- |
| Liquidia Corp | 577.21m | -3.89bn | 31.89bn | 136.00 | -- | 10.21 | -- | 55.25 | -1.57 | -1.57 | 0.2359 | 1.13 | 0.098 | -- | 4.77 | 117,404.40 | -66.06 | -55.02 | -72.44 | -62.69 | 76.82 | 82.18 | -674.42 | -474.59 | 7.50 | -28.61 | 0.4944 | -- | 9.75 | 45.23 | -91.40 | -- | 66.93 | -- |
| Mega Lifesciences PCL | 15.69bn | 2.02bn | 32.48bn | 5.51k | 16.11 | 3.27 | 14.10 | 2.07 | 2.31 | 2.31 | 17.98 | 11.40 | 1.08 | 2.19 | 5.18 | 2,845,188.00 | 13.88 | 14.06 | 20.28 | 22.34 | 46.01 | 42.78 | 12.86 | 12.57 | 1.66 | 4.06 | 0.0324 | 47.14 | -0.0322 | 8.68 | -11.10 | 10.56 | -17.15 | 17.64 |
| China Animal Husbandry Industry Co., Ltd | 27.18bn | 1.68bn | 32.88bn | 4.33k | 19.51 | 1.18 | -- | 1.21 | 0.3321 | 0.3321 | 5.36 | 5.48 | 0.6331 | 4.13 | 4.89 | 1,264,384.00 | 3.33 | 6.23 | 4.71 | 9.01 | 18.95 | 24.29 | 5.26 | 8.69 | 1.86 | -- | 0.2017 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
| Blue Jet Healthcare Ltd | 3.07bn | 707.39m | 32.95bn | -- | 46.56 | 9.02 | 39.76 | 10.72 | 9.44 | 9.44 | 41.04 | 48.73 | 0.7409 | 2.46 | 3.42 | -- | 17.05 | -- | 21.25 | -- | 55.82 | -- | 23.01 | -- | 2.80 | 1,257.13 | 0.00 | -- | -1.30 | -- | 2.33 | -- | -- | -- |
| Beijing Tong Ren Tang Chinese Medicine | 7.06bn | 2.50bn | 33.05bn | 798.00 | 13.21 | 1.85 | 10.61 | 4.68 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Beijing Foyou Pharma Co Ltd | 16.51bn | 2.52bn | 33.27bn | 3.44k | 13.14 | 1.90 | -- | 2.01 | 1.06 | 1.06 | 6.95 | 7.35 | 0.7482 | 3.46 | 9.58 | 967,165.90 | 11.50 | -- | 14.81 | -- | 65.14 | -- | 15.37 | -- | 2.99 | -- | 0.0316 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
| Pacira Biosciences Inc | 24.65bn | 2.55bn | 33.62bn | 711.00 | 15.42 | 1.04 | 6.42 | 1.36 | 1.30 | 1.30 | 12.11 | 19.18 | 0.4389 | 1.93 | 7.00 | 958,866.40 | 4.54 | 3.35 | 4.84 | 3.98 | 73.15 | 72.63 | 10.34 | 8.57 | 4.78 | 51.11 | 0.3684 | 0.00 | 1.22 | 14.88 | 163.72 | -- | 0.8761 | -- |
Data as of Jul 24 2024. Currency figures normalised to Mega Lifesciences PCL's reporting currency: Thai Baht THB
6.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 23.92m | 2.74% |
| Aberdeen Asset Management (Thailand) Co., Ltd.as of 29 Mar 2024 | 15.13m | 1.74% |
| Lazard Asset Management LLCas of 30 Sep 2023 | 7.67m | 0.88% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 3.64m | 0.42% |
| Epoch Investment Partners, Inc.as of 31 Dec 2023 | 2.06m | 0.24% |
| SCB Asset Management Co., Ltd.as of 29 Mar 2024 | 1.97m | 0.23% |
| AllianceBernstein Ltd.as of 31 Mar 2024 | 1.94m | 0.22% |
| FIL Investment Management (Singapore) Ltd.as of 31 May 2024 | 1.58m | 0.18% |
| Kiatnakin Phatra Asset Management Co. Ltd.as of 29 Mar 2024 | 1.56m | 0.18% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 1.49m | 0.17% |
More ▼
Data from 31 Dec 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.
